Status:
WITHDRAWN
Resting-state Functional Connectivity Changes During Migraine Treatment
Lead Sponsor:
Samsung Medical Center
Collaborating Sponsors:
SK Chemicals Co., Ltd.
Conditions:
Migraine Disorders
Eligibility:
FEMALE
18-50 years
Brief Summary
The purpose of this study is to determine whether reduced frequency of migraine attacks are associated with signal alternation and connectivity of cerebral cortex.
Detailed Description
Patients with migraine show reduced cortical thickness in regions subserving pain processing, and it is related to increasing headache frequency. In the past, only one study has shown a reversibility ...
Eligibility Criteria
Inclusion
- Premenopausal Women
- Aged 18-50
- Drug-naïve high frequency episodic migraineurs (8-14 attacks/m)
- Performed a baseline interictal brain MRI
Exclusion
- Medication overuse
- Chronic pain other than migraine
- On treatment of major depression, bipolar, schizophrenia, or BDI\>25
Key Trial Info
Start Date :
May 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03484871
Start Date
May 1 2016
End Date
April 1 2019
Last Update
March 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea